NFG
PCRX icon

Next Financial Group’s Pacira BioSciences PCRX Stock Holding History

Next Financial Group’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$27K Sell
450
-345
-43% -$19K ﹤0.01% 1757
2021
Q3 		$45K Hold
795
– – ﹤0.01% 1454
2021
Q2 		$48K Hold
795
– – ﹤0.01% 1395
2021
Q1 		$56K Sell
795
-655
-45% -$46.8K 0.01% 1237
2020
Q4 		$87K Hold
1,450
– – 0.01% 1004
2020
Q3 		$87K Buy
+1,450
New +$84.3K 0.01% 916

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Next Financial Group's PCRX Position: Q4 2021 in Review

Next Financial Group reduced its Pacira BioSciences (PCRX) stake by 43% in Q4 2021, selling an estimated $19K and leaving 450 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

Next Financial Group first reported a position in PCRX in Q3 2020 and has held it in 6 quarters since. The position peaked at $87K in Q4 2020. 276 funds tracked by Wall St. Rank hold PCRX as of Q4 2021.

  • Next Financial Group held 450 shares of Pacira BioSciences worth $27K as of Q4 2021.
  • Next Financial Group sold 345 Pacira BioSciences shares in Q4 2021, an estimated $19K.
  • Pacira BioSciences made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #1757 holding.
  • Next Financial Group first reported a position in Pacira BioSciences in Q3 2020 and has held it in 6 quarters since.
  • Next Financial Group's Pacira BioSciences position peaked at $87K in Q4 2020.
  • 276 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.